If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    -0.50 (-2.78%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Director Dealing

20 Apr 2022 09:04

RNS Number : 7320I
Mission Group PLC (The)
20 April 2022
 

 

 

 

 

The Mission Group plc

("MISSION" "The Company" or "The Group") 

 

Director Dealing

 

 

MISSION (AIM:TMG), the alternative group for ambitious brands, announces that as part of his annual remuneration package, James Clifton, Group Chief Executive, has been issued ordinary shares of 10 pence each ("Ordinary Shares") in the Company to the value of £30,000 ("Remuneration Shares").

 

The Remuneration Shares were issued at a price of 65.4p per share, being the daily average closing price for the Company's shares for the five days preceding 9 April 2022, the anniversary of his appointment as Group Chief Executive, resulting in a total of 45,872 Ordinary Shares.

 

The Remuneration Shares give rise to PAYE and NI liabilities and, as such, Mr Clifton has elected to receive such number of Remuneration Shares net-of-tax, being 23,739 Ordinary Shares.

 

These Remuneration Shares were transferred to Mr Clifton from The Mission Group Employee Benefit Trust ("EBT") on 19 April 2022.

 

Following the transfer of the Remuneration Shares, net-of-tax, from the EBT to Mr Clifton, Mr Clifton is interested in 555,834 Ordinary Shares, equal to approximately 0.6% of the issued share capital of the Company.

 

Following the transfer of shares from the EBT to Mr Clifton, a total of 667,601 Ordinary Shares, representing 0.7% of the Company's total voting rights, are held in the EBT.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014. The notification below provides further detail.

 

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

Mark Percy / James Thomas / Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

 

Kate Hoare / Laura Stewart

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

NOTES TO EDITORS

 

MISSION is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit. Employing 1,000 people across 29 locations and 3 continents, the Group successfully combines its diverse expertise to produce Work That Counts for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands. www.themission.co.uk

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Clifton

 

2

 

Reason for the notification

a)

 

Position/status

 

 

James Clifton

 Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

20 April 2022

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

The Mission Group plc

b)

 

LEI

213800L567CF3Z6GPZ03

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 10 pence each

 

 

GB00B11FD453

b)

 

Nature of the transaction

 

 

Shares issued as part of remuneration package

c)

 

Price(s) and volume(s)

 

 

23,739 Ordinary Shares

65.4p per share

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

 

 

23,739

 

65.4p

e)

 

Date of the transaction

 

 

19 April 2022

f)

 

Place of the transaction

 

 

Off-market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSESSASEESESL
Date   Source Headline
23rd Oct 20137:00 amRNSAcquisition of Solaris Healthcare Network Limited
3rd Oct 20134:44 pmRNSDirector Exercise of Options & EBT dealing
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results
6th Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
28th Jan 20137:00 amRNSTrading Update
25th Jan 20137:00 amRNSNew Client win and further expansion
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 201211:44 amRNSHolding(s) in Company
16th Oct 20122:59 pmRNSHolding(s) in Company
12th Oct 20127:00 amRNSAcquisition, Placing and Board Appointment
24th Sep 20127:00 amRNSAcquisition of Addiction Worldwide
19th Sep 20128:19 amRNSHalf Yearly Report
14th Sep 20123:14 pmRNSNotice of Half Year Results
20th Jul 20127:00 amRNSIssue of LTIP Awards
18th Jul 20127:01 amRNSPre Close Trading Update
18th Jul 20127:00 amRNSChange of Adviser
18th Jun 20121:03 pmRNSResult of AGM
18th Jun 201212:00 pmRNSDirectorate Change
31st May 20121:30 pmRNSContract Award
14th May 20124:04 pmRNSDirector/PDMR Shareholding
8th May 20122:01 pmRNSDirector/PDMR Shareholding
4th May 20122:47 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSDirector/PDMR Shareholding
16th Apr 20123:34 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSFinal Results
22nd Mar 20127:00 amRNSNotice of Results
26th Jan 20127:00 amRNSTrading Statement
24th Jan 20127:00 amRNSDirector/PDMR Shareholding
6th Jan 20129:13 amRNSDirector/PDMR Shareholding
21st Nov 20114:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.